Centogene
Centogene Q2 Revenues Continue to Benefit From COVID-19 Testing as Core Business Starts to Recover
The German rare disease diagnostics company had €51.9 million in Q2 revenues, significantly beating the average Wall Street estimate.
Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing
Core diagnostic testing revenues were €6.4 million, down 15 percent year over year, while pharmaceutical revenues totaled €3.6 million, down 22 percent.
Dec 16, 2020
Centogene Q3 Revenues Triple on COVID-19 Testing
Sep 23, 2020
Centogene Reports 13 Percent Decline in Q2 Revenues
Jul 10, 2020
Centogene to Raise $28M in Public Stock Offering
Jun 15, 2020
Centogene Q1 Revenues Increase 13 Percent
Apr 23, 2020